Q3 FY2025 Earnings
Financial report interval: 2025.06.30 - 2025.09.30
Overview: CureVac BV(CVAC) the Revenue is 63.49 M (-88.49%);the EBIT is 363.8 M (-11.55%);the EPS is 1.76 (+30.2%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.06B88.49%
----
----
EBIT
0.36B11.55%
----
----
EPS
1.759130.20%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf